Gui Fu Zhang
Direttore/Membro del Consiglio presso New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
Profilo
Gui Fu Zhang is currently an Executive Director at China Pharmaceutical Co. Ltd., CMP Group Ltd.
(Samoa), and New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
In the past, she worked as an Executive Director at SSY Group Ltd.
from 2010 to 2012 and as an Executive Director & Finance Manager at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
from 2011 to 2013.
Posizioni attive di Gui Fu Zhang
| Società | Posizione | Inizio |
|---|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Direttore/Membro del Consiglio | 23/03/2010 |
China Pharmaceutical Co. Ltd.
 China Pharmaceutical Co. Ltd. Financial ConglomeratesFinance China Pharmaceutical Co. Ltd. operates as an investment holding Chinese company. | Direttore/Membro del Consiglio | 09/09/2011 |
CMP Group Ltd. (Samoa)
 CMP Group Ltd. (Samoa) Financial ConglomeratesFinance Part of China Pharmaceutical Co. Ltd., CMP Group Ltd. (Samoa) operates a Samoan investment company. | Direttore/Membro del Consiglio | 09/09/2011 |
Precedenti posizioni note di Gui Fu Zhang
| Società | Posizione | Fine |
|---|---|---|
| SSY GROUP LIMITED | Direttore/Membro del Consiglio | 05/04/2012 |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Direttore Finanziario/CFO | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Aziende private | 4 |
|---|---|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
China Pharmaceutical Co. Ltd.
China Pharmaceutical Co. Ltd. Financial ConglomeratesFinance China Pharmaceutical Co. Ltd. operates as an investment holding Chinese company. | Finance |
CMP Group Ltd. (Samoa)
CMP Group Ltd. (Samoa) Financial ConglomeratesFinance Part of China Pharmaceutical Co. Ltd., CMP Group Ltd. (Samoa) operates a Samoan investment company. | Finance |
- Borsa valori
- Insiders
- Gui Fu Zhang
